Mass General Brigham Cancer Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Mass General Brigham Cancer Institute brings 1 presentation to ASH 2026 in New Orleans. Its program centres on applying new evidence in everyday care of myeloproliferative neoplasms and newly diagnosed multiple myeloma. It also offers career advice on non-traditional academic paths for early faculty.
| Organization | ASH 2026 Attendance |
|---|---|
Mass General Brigham Cancer Institute Boston, MA | |
Cancer care and research institute of the Mass General Brigham health system in Boston. | Symposium Fri Dec 11 3:00pm–6:00pm Cases and Conversations™: Applying Emerging Evidence to Real-World Care in Myeloproliferative Neoplasms Choosing among new myeloproliferative neoplasm drugs, including Janus kinase and telomerase inhibitors, hepcidin mimetics, and calreticulin-targeted antibodies. Symposium Fri Dec 11 11:00am–2:00pm Transforming Care for Newly-Diagnosed Multiple Myeloma: Integrating Evidence-Based Innovation into Community Practice Newly diagnosed multiple myeloma care in community clinics, using frailty assessment, dose adjustment to protect quality of life, and new drug formulations. |
Instantly find 20 buyers from Mass General Brigham Cancer Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction